TickerFacts.

Becton Dickinson & Co (BDX): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2010-09-30, 2020-09-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.26B
Year ended 2025-09-30
+0.2%
3-year compound annual growth
+4.0%
5-year compound annual growth
$1.28B2009-09-30: $404.57M2010-09-30: $422.77M2011-09-30: $470.00M2012-09-30: $472.00M2013-09-30: $494.00M2014-09-30: $550.00M2015-09-30: $632.00M2016-09-30: $828.00M2017-09-30: $770.00M2018-09-30: $1.00B2019-09-30: $1.06B2020-09-30: $1.04B2021-09-30: $1.28B2022-09-30: $1.26B2023-09-30: $1.24B2024-09-30: $1.19B2025-09-30: $1.26B$1.26B
2009-09-30 R&D Expense (USD) 2025-09-30
Period endedR&D ExpenseChange YoYSource filing
2025-09-30$1.26B+6.3%2025-11-25, From 2024-10-01
2024-09-30$1.19B-3.8%2025-11-25, From 2023-10-01
2023-09-30$1.24B-1.5%2025-11-25, From 2022-10-01
2022-09-30$1.26B-1.8%2024-11-27, From 2021-10-01
2021-09-30$1.28B+23.1%2023-11-21, From 2020-10-01
2020-09-30$1.04Bn/c2022-11-22, From 2019-10-01
2019-09-30$1.06B+5.8%2021-11-24, From 2018-10-01
2018-09-30$1.00B+30.4%2020-11-25, From 2017-10-01
2017-09-30$770.00M-7.0%2019-11-27, From 2016-10-01
2016-09-30$828.00M+31.0%2018-11-21, From 2015-10-01
2015-09-30$632.00M+14.9%2017-11-22, From 2014-10-01
2014-09-30$550.00M+11.3%2016-11-23, From 2013-10-01
2013-09-30$494.00M+4.7%2015-11-25, From 2012-10-01
2012-09-30$472.00M+0.4%2014-11-26, From 2011-10-01
2011-09-30$470.00M+11.2%2013-11-27, From 2010-10-01
2010-09-30$422.77Mn/c2012-11-21, From 2009-10-01
2009-09-30$404.57Mn/a2011-11-23, From 2008-10-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Becton Dickinson & Co (BDX)2025-09-30$1.26B+6.3%
Boston Scientific Corp (BSX)2025-12-31$2.05B+27.1%
3M Co (MMM)2024-12-31$700.00M0.0%
Stryker Corp (SYK)2025-12-31$1.62B+10.7%
Medline Inc. (MDLN)2025-12-31$80.00M+19.4%
Baxter International Inc (BAX)2025-12-31$518.00M-12.2%
Solventum Corp (SOLV)2025-12-31$739.00M-4.6%
ResMed Inc (RMD)2026-06-30$378.29M+14.2%
Dexcom Inc (DXCM)2025-12-31$599.10M+8.5%

Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗